Related Experiment Video
Updated: Jul 15, 2026

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment
Published on: December 27, 2024
[Gastroduodenal ulcer refractory to conservative treatment]
Natalia Velenciuc1, C Melinte, I Velenciuc
1Facultatea de Medicina, Universitatea de Medicina şi Farmacie "Gr.T.Popa", Iaşi.
Abstract:
This is a 20-year retrospective study on 205 patients in which surgery for gastroduodenal ulcer was performed. In 51 one of these patients (24,8%) surgery was required by drug therapy failure, cases labeled as drug-resistant ulcers. Some causes of drug therapy failure are discussed, failure being also recorded in patients who benefited from modem ulcer drugs that proved only partially effective. The authors emphasize that surgery can no longer represent a therapeutic option, an utter substantiation not only from the surgeon but also from the entire team of specialists in various investigation types and therapeutics being mandatory.
Insights
Surgery for gastroduodenal ulcers is increasingly rare due to drug therapy failures. A 20-year study found drug-resistant ulcers necessitate a multidisciplinary approach, questioning surgery as a primary option.
Area of Science:
- Gastroenterology
- Surgical Gastroenterology
- Pharmacology
Context:
- Retrospective analysis of 205 patients undergoing gastroduodenal ulcer surgery over 20 years.
- Identified 51 cases (24.8%) of drug-resistant ulcers requiring surgical intervention.
- Explored reasons for drug therapy failure, including partially effective modern ulcer medications.
Purpose:
- To evaluate the role of surgery in managing gastroduodenal ulcers in the context of evolving medical therapies.
- To analyze the incidence and causes of drug-resistant gastroduodenal ulcers.
- To emphasize the need for a comprehensive, team-based approach to ulcer management.
Summary:
- Surgery for gastroduodenal ulcers was performed on 205 patients over two decades.
- Drug therapy failure led to surgery in 24.8% of cases, defined as drug-resistant ulcers.
- The study highlights that surgery is no longer a primary therapeutic option, necessitating a multidisciplinary evaluation.
Impact:
- Challenges the traditional role of surgery in gastroduodenal ulcer treatment.
- Underscores the importance of a collaborative specialist approach for complex ulcer cases.
- Suggests a shift towards non-surgical management strategies for most gastroduodenal ulcers.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease III: Clinical Manifestations and Complications